Quarterly report pursuant to Section 13 or 15(d)

Equity

v3.22.0.1
Equity
6 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Equity

Note 11. Equity

 

Equity Offering Program

 

The Company has in place an ATM Equity OfferingSM Sales Agreement with BofA Securities, Inc. and Piper Sandler & Co. (the “Sales Agreement”), pursuant to which the Company may sell from time-to-time shares of its common stock having an aggregate offering price of up to $100 million (the “Equity Offering Program”). As of December 31, 2021, the Company had sold an aggregate of $93.0 million of its shares in the Equity Offering Program.

 

The following table summarizes sales through the Equity Offering Program during the six months ended December 31, 2021:

 

Three months ended   Avg price
per share
    Number of
Shares
    Gross
Proceeds
(in millions)
    Offering
Expenses
(in millions)
 
    Net
Proceeds
(in millions)
 
September 30, 2021   $ 9.99       555,455     $ 5.5     $ 0.1     $ 5.4  
December 31, 2021   $ 7.04       1,931,022     $ 13.6     $ 0.2     $ 13.4  
Total   $ 7.70       2,486,477     $ 19.1     $ 0.3     $ 18.8  

 

Equity Incentive Plans

 

During the six months ended December 31, 2021, the Company granted employees options to purchase an aggregate of approximately 0.6 million shares of common stock. The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following assumptions:

 

    Six Months
Ended
December 31,
2021
 
Exercise price   $ 6.76 –10.15  
Expected term (years)     4.75 – 5.00  
Volatility     66-67 %
Risk-free interest rate     0.76%–1.14 %
Dividend yield     0 %
Weighted Average Grant Date Fair Value of Options granted during the period   $ 5.23  

  

During the six months ended December 31, 2021 the Company awarded certain employees and directors grants of an aggregate of approximately 0.9 million restricted stock units (“RSUs”) with a weighted average grant date fair value of $9.23. The RSUs will be expensed over the requisite service period. The terms of the RSUs include vesting provisions based solely on continued service. If the service criteria are satisfied, the RSUs will generally vest over 4 – 5 years.

 

Compensation expense related to our stock-based awards described above was as follows (in thousands):

 

    Three Months Ended
December 31,
    Six Months Ended
December 31,
 
    2021     2020     2021     2020  
Research and Development   $ 1,716     $ 928     $ 2,948     $ 1,942  
General and Administrative     1,184       1,138       2,300       2,151  
Total   $ 2,900     $ 2,066     $ 5,248     $ 4,093  

 

Unrecognized stock-based compensation expense and weighted-average years to be recognized are as follows (in thousands):

 

    As of December 31, 2021  
    Unrecognized
stock-based
compensation
    Weighted-
average years
to be recognized
 
Options   $ 4,082       2.53  
Restricted stock units   $ 12,271       2.37